|
1
|
Satar M and Ozlü F: Neonatal sepsis: A
continuing disease burden. Turk J Pediatr. 54:449–457.
2012.PubMed/NCBI
|
|
2
|
Liu L, Johnson HL, Cousens S, Perin J,
Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, et al:
Global, regional and national causes of child mortality: An updated
systematic analysis for 2010 with time trends since. Lancet.
379:2151–2161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raymond SL, Stortz JA, Mira JC, Larson SD,
Wynn JL and Moldawer LL: Immunological defects in neonatal sepsis
and potential therapeutic approaches. Front Pediatr. 5:142017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu YQ, Shen J, Zhou QL, Zhao HW, Liu LR
and Liu X: Interleukin-6 and interleukin-8 in diagnosing neonatal
septicemia. J Biol Regul Homeost Agents. 30:1107–1113.
2016.PubMed/NCBI
|
|
5
|
Delanghe JR and Speeckaert MM:
Translational research and biomarkers in neonatal sepsis. Clin Chim
Acta. 451:46–64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anderson AE, Pratt AG, Sedhom MA, Doran
JP, Routledge C, Hargreaves B, Brown PM, Cao Lê KA, Isaacs JD and
Thomas R: IL-6-driven STAT signalling in circulating CD4+
lymphocytes is a marker for early anticitrullinated peptide
antibody-negative rheumatoid arthritis. Ann Rheum Dis. 75:466–473.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tezono K, Sarker KP, Kikuchi H, Nasu M,
Kitajima I and Maruyama I: Bioactivity of the vascular endothelial
growth factor trapped in fibrin clots: Production of IL-6 and IL-8
in monocytes by fibrin clots. Haemostasis. 31:71–79.
2001.PubMed/NCBI
|
|
8
|
Vila N, Reverter JC, Yague J and Chamorro
A: Interaction between interleukin-6 and the natural anticoagulant
system in acute stroke. J Interferon Cytokine Res. 20:325–329.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Celik HT, Portakal O, Yigit S, Hascelik G,
Korkmaz A and Yurdakok M: Efficacy of new leukocyte parameters
versus serum C-reactive protein, procalcitonin and interleukin-6 in
the diagnosis of neonatal sepsis. Pediatr Int. 58:119–125. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Steinberger E, Hofer N and Resch B: Cord
blood procalcitonin and Interleukin-6 are highly sensitive and
specific in the prediction of early-onset sepsis in preterm
infants. Scand J Clin Lab Invest. 74:432–436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu Z, Xiao SB, Xu P, Xie Q, Cao L, Wang D,
Luo R, Zhong Y, Chen HC and Fang LR: miR-365, a novel negative
regulator of interleukin-6 gene expression, is cooperatively
regulated by Sp1 and NF-kappaB. J Biol Chem. 286:21401–21412. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Subspecialty Group of Neonatology
Pediatric Society Chinese Medical Association, . Editorial Board
Chinese Journal of Pediatrics. Protocol for diagnosis and treatment
of neonatal septicemia. Zhonghua Er Ke Za Zhi. 41:897–899. 2003.(In
Chinese). PubMed/NCBI
|
|
13
|
Qazi SA and Stoll BJ: Neonatal sepsis: A
major global public health challenge. Pediatr Infect Dis J. 28 1
Suppl:S1–S2. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou M, Cheng S, Yu J and Lu Q:
Interleukin-8 for diagnosis of neonatal sepsis: A meta-analysis.
PLoS One. 10:e01271702015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tunc T, Cekmez F, Cetinkaya M, Kalayci T,
Fidanci K, Saldir M, Babacan O, Sari E, Erdem G, Cayci T, et al:
Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis. J
Matern Fetal Neonatal Med. 28:356–361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lv B, Huang J, Yuan H, Yan W, Hu G and
Wang J: Tumor necrosis factor-α as a diagnostic marker for neonatal
sepsis: A meta-analysis. ScientificWorldJournal. 2014:4714632014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
DeLong WG Jr and Born CT: Cytokines in
patients with polytrauma. Clin Orthop Relat Res. 1–65.
2004.PubMed/NCBI
|
|
18
|
Stover JF, Sakowitz OW, Schoning B,
Rupprecht S, Kroppenstedt SN, Thomale UW, Woiciechowsky C and
Unterberg AW: Norepinephrine infusion increases interleukin-6 in
plasma and cerebrospinal fluid of brain-injured rats. Med Sci
Monit. 9:Br382–Br388. 2003.PubMed/NCBI
|
|
19
|
Baeuerle PA and Henkel T: Function and
activation of NF-kappa B in the immune system. Annu Rev Immunol.
12:141–179. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tone M, Powell MJ, Tone Y, Thompson SA and
Waldmann H: IL-10 gene expression is controlled by the
transcription factors Sp1 and Sp3. J Immunol. 165:286–291. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo Q, Ma X, Wahl SM, Bieker JJ, Crossley
M and Montaner LJ: Activation and repression of interleukin-12 p40
transcription by erythroid Kruppel-like factor in macrophages. J
Biol Chem. 279:18451–18456. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Riedemann NC, Neff TA, Guo RF, Bernacki
KD, Laudes IJ, Sarma JV, Lambris JD and Ward PA: Protective effects
of IL-6 blockade in sepsis are linked to reduced C5a receptor
expression. J Immunol. 170:503–507. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pritts T, Hungness E, Wang Q, Robb B,
Hershko D and Hasselgren PO: Mucosal and enterocyte IL-6 production
during sepsis and endotoxemia-role of transcription factors and
regulation by the stress response. Am J Surg. 183:372–383. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Varshney J and Subramanian S: MicroRNAs as
potential target in human bone and soft tissue sarcoma
therapeutics. Front Mol Biosci. 2:312015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Witwer KW, Sisk JM, Gama L and Clements
JE: MicroRNA regulation of IFN-beta protein expression: Rapid and
sensitive modulation of the innate immune response. J Immunol.
184:2369–2376. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jones MR, Quinton LJ, Blahna MT, Neilson
JR, Fu S, Ivanov AR, Wolf DA and Mizgerd JP: Zcchc11-dependent
uridylation of microRNA directs cytokine expression. Nat Cell Biol.
11:1157–1163. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rogler CE, Levoci L, Ader T, Massimi A,
Tchaikovskaya T, Norel R and Rogler LE: MicroRNA-23b cluster
microRNAs regulate transforming growth factor-beta/bone
morphogenetic protein signaling and liver stem cell differentiation
by targeting Smads. Hepatology. 50:575–584. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luzi E, Marini F, Sala SC, Tognarini I,
Galli G and Brandi ML: Osteogenic differentiation of human adipose
tissue-derived stem cells is modulated by the miR-26a targeting of
the SMAD1 transcription factor. J Bone Miner Res. 23:287–295. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen L, Zheng J, Zhang Y, Yang L, Wang J,
Ni J, Cui D, Yu C and Cai Z: Tumor-specific expression of
microRNA-26a suppresses human hepatocellular carcinoma growth via
cyclin-dependent and -independent pathways. Mol Ther. 19:1521–1528.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF and Li XP: MiR-26a inhibits
cell growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang B, Liu XX, He JR, Zhou CX, Guo M, He
M, Li MF, Chen GQ and Zhao Q: Pathologically decreased miR-26a
antagonizes apoptosis and facilitates carcinogenesis by targeting
MTDH and EZH2 in breast cancer. Carcinogenesis. 32:2–9. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kota J, Chivukula RR, O'Donnell KA,
Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P,
Torbenson M, Clark KR, et al: Therapeutic microRNA delivery
suppresses tumorigenesis in a murine liver cancer model. Cell.
137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ciarapica R, Russo G, Verginelli F,
Raimondi L, Donfrancesco A, Rota R and Giordano A: Deregulated
expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle.
8:172–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang X, Liang L, Zhang XF, Jia HL, Qin Y,
Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, et al: MicroRNA-26a
suppresses tumor growth and metastasis of human hepatocellular
carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology.
58:158–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
